HR-6009 : Still Just a Bill

---

The Defense Biotechnology Strategy Act, also known as H.R. 6009, directs the Secretary of Defense to develop a strategy regarding the national security implications of emerging biotechnologies.

The strategy, to be submitted to the House and Senate Armed Services Committees within one year of the Act's enactment, shall include the following elements:

• Development and expansion of a network of commercial facilities for biomanufacturing products critical for defense needs.
• Review and update of military specifications to better incorporate or substitute current products with biotechnology-based products.
• Updated plans and policies for the Department of Defense to enter into advance market commitments and offtake agreements for biotechnology products with defense applications.
• A description of how the Department could better incorporate military-relevant applications of emerging biotechnology into wargaming exercises, tabletop exercises, or other net assessment analyses.
• An assessment of the benefits and costs of issuing a research grand challenge, or a series of challenges, that focus on making biotechnology predictably engineerable and how the Department would implement such research grand challenge, or challenges.
• Development of a biotechnology regulation science and technology program within the Department, including development of digital infrastructure to support simplified regulation and the development of biometrology tools.
• Updated plans and policies for inter-governmental support that the Department could provide in encouraging member countries of the North Atlantic Treaty Organization (NATO) to aggregate demand and pool purchasing power for biotechnology products.
• A review of plans and guidance on how the Department can work to develop, integrate, and disseminate biotechnology research initiatives across member countries of NATO, and how the Department might coordinate with international stakeholders to utilize the combined research capabilities of such member countries to drive a biotechnology development approach.

---

An error occured and we cannot provide a prediction at this time. Either Congress API has not provided a text file or subject list for this bill, or the bill text is too large to make a prediction.